FILTER

LATEST INTERVIEWS

United States
Pharma & Life Sciences

Jay Shukla

PRESIDENT AND CEO, NIVAGEN PHARMACEUTICALS, INC.
"Our partners benefit from our market intelligence and cost-splitting, and we attain the manufacturing capability and resources. We will continue to grow our partnership model now that we are expecting to double our revenue."
Petrochemicals & Chemicals
Singapore
Malaysia

Paul Fong

MANAGING DIRECTOR, DOW MALAYSIA AND SINGAPORE
"As a leading materials science company, we are prepared to respond quickly when the situation improves. With China finally reopening after COVID, there is a silver lining for spillover growth."
United States
Pharma & Life Sciences

Robert Poe

CEO, OLON RICERCA BIOSCIENCES
"What we are doing here is beginning the build-out of a high-potency API suite, so that we can get up to a few hundred grams made for early studies and transfer those processes to our sites in Italy for the clinical trial phase."
Mining
Canada

Gus Minor

CHIEF INNOVATION OFFICER, SOFVIE
"When digital tools are too difficult to use, they end up being abandoned, so we developed Sofvie directly with the workforce to make sure that it is user-friendly."
Mining
Canada

James Withall

CEO, RUPERT RESOURCES
"We are working with the authorities to make sure they have the information they need to make a very informed, defensible decision about permitting the project. From that perspective, Finland is a very good place to work."
Mexico
Petrochemicals & Chemicals

Miguel Valdivia

GENERAL MANAGER, TRADE CHEMICALS & PRODUCTS
"In 2022, the industry experienced shortages, but these shortages benefited TCP. Our clients needed to look for different products, and we were able to help them find what they needed."
Mining
Mexico

Baltazar Manfro

CEO, PLASTIGLAS
"We aim to maintain and expand our market share as the leader in Canada and the US and increase our market share in Mexico. We also want to continue growing in Central and South America."
United States
Pharma & Life Sciences

Manni Kantipudi & Ramesh Subramanian

CHIEF EXECUTIVE OFFICER (MK) & CHIEF COMMERCIAL OFFICER (RS), ARAGEN LIFE SCIENCES
"Overall, I believe the virtual biotech model is here to stay and companies will increasingly look at CRO/CDMO companies for assistance in taking drugs from discovery to commercialization."
United States
Pharma & Life Sciences

Chris Garabedian

CHAIRMAN AND CEO, XONTOGENY, AND PORTFOLIO MANAGER, PERCEPTIVE XONTOGENY VENTURE (PXV) FUND
"Following a long period of significant investment in early-stage firms, our industry needs to allow existing investments across the industry to mature and show signs of success before driving new investments in preclinical-stage projects."
Mining
Peru
SPANISH

Gustavo Bravo & Gonzalo Covarrubias

DIRECTOR DE MINERÍA PARA LATINOAMÉRICA Y CARIBE (GB) & GERENTE GENERAL PERÚ (GC), WSP
“Para WSP los criterios ESG son de suma importancia y la incorporación de la experiencia del equipo de E&I de Wood robusteció nuestras capacidades en la gestión, diseño y aplicación de nuevas tecnologías de relaves bajo estos criterios.”

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2025 - Pre-release

This pre-release, containing insights from executives across leading African upstream, downstream, financing, and service providers, spotlights developments in local capabilities, infrastructure, and new projects that are driving change in some of Africa's most interesting oil and gas producing countries. 
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL